Sort
46,585 grants matching “heart failure”
Chronic Kidney Disease Prognosis Consortium
$718,524Josef Coresh · Johns Hopkins University · R01 · FY2014 · DK
Longitudinal study of determinants of medication adherence in COPD
$718,399Michelle Nuttall Eakin · Johns Hopkins University · R01 · FY2016 · HL
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
$718,366George L Anesi · University Of Pennsylvania · R01 · FY2024 · HL
Treatment of Functional Impairment in Heart Failure Patients with Depression
$718,347Kenneth E Freedland · Washington University · R01 · FY2012 · HL
CVD in American Indians Biomarker lab and Arizona Field Center
$718,329Barbara V Howard · Medstar Health Research Institute · R01 · FY2013 · HL
CVD in American Indians Biomarker lab and Arizona Field Center
$718,329Jason G Umans · Medstar Health Research Institute · R01 · FY2017 · HL
CVD in American Indians Biomarker lab and Arizona Field Center
$718,329Jason G Umans · Medstar Health Research Institute · R01 · FY2016 · HL
TREATMENT OF FUNCTIONAL IMPAIRMENT IN PATIENTS WITH HEART FAILURE AND COMORBID DE
$718,319Kenneth E Freedland · Washington University · R01 · FY2010 · HL
Silencing cardiac-specific microRNAs to prevent pathological remodeling in conges
$718,304Matthew Swan Lawrence · Virscio, Inc. · R43 · FY2011 · HL
Cardiac Myocyte Protein Partners in Heart Function
$718,281Robert Scott Ross · University Of California, San Diego · R01 · FY2025 · HL
Cardiac Myocyte Protein Partners in Heart Function
$718,281Robert Scott Ross · University Of California, San Diego · R01 · FY2023 · HL
Vaccine Induced Immune-Inflammatory Response and Cardiovascular Risk
$718,171Susan Cheng · Cedars-Sinai Medical Center · R01 · FY2024 · HL
Uremic Toxins and Cardiovascular Disease
$718,091Sharon M Moe · Indiana University Indianapolis · R01 · FY2024 · HL
Integrative Omics, Chronic Kidney Disease, and Adverse Outcomes in Older Adults
$718,068Morgan Erika Grams · Johns Hopkins University · R01 · FY2020 · DK
Determinants, Trajectories, and Consequences of Abnormal Cardiac Mechanics
$718,053Sanjiv J Shah · Northwestern University At Chicago · R01 · FY2016 · HL
Preclinical Efficacy And Safety Evaluation Of Graphene Nanoparticle-based Magnetic Resonance Imaging Contrast Agent For Diagnosis of Renal Failure
$717,997Balaji Sitharaman · Theragnostic Technologies, Inc. · R44 · FY2016 · DK
iPS cells-derived progenitor cells for angiomyogenesis
$717,972Yigang Wang · University Of Cincinnati · R01 · FY2014 · HL
Predictors of cardiomyopathy progression in a Chagas disease cohort in Bolivia
$717,912Robert H Gilman · Johns Hopkins University · R01 · FY2023 · AI
Polypill strategy for the evidence-based management of heart failure with reduced ejection fraction in an underserved patient population
$717,793Ambarish Pandey · Ut Southwestern Medical Center · R01 · FY2023 · MD
Dynamic Longitudinal Functional Models with Applications to the CRIC Study
$717,748Wensheng Guo · University Of Pennsylvania · R01 · FY2023 · HL
Mechanisms and Therapeutic Targeting of T cell Regulation in Heart Allograft Recipient Monkeys
$717,706Mohamed B Ezzelarab · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · AI
Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients
$717,699Majid Afshar · University Of Wisconsin-Madison · R01 · FY2022 · DA
Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis
$717,697Peter Ganz · University Of California, San Francisco · R01 · FY2021 · HL
Gene Expression and Thrombosis in a Community Based Cohort Study
$717,694Jane E Freedman · Boston University Medical Campus · R01 · FY2009 · HL
Diversity of TFH cells and DSA generation after kidney transplantation
$717,584Diana M Metes · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI